Burning Rock Biotech Limited - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
BNR Nasdaq 2830 www.brbiotech.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Burning Rock Biotech Limited

Burning Rock Announces Founder’s Purchase of Its ADSs - Jul 2nd, 2026 5:19 am
Burning Rock Reports First Quarter 2026 Financial Results - Jun 9th, 2026 4:38 am
Burning Rock Publishes 2025 Annual Report on Form 20-F - Apr 28th, 2026 4:45 am
Brenntag Q4 Earnings Call Highlights - Mar 12th, 2026 8:48 am
Burning Rock Reports Unaudited Fourth Quarter and Full Year 2025 Financial Results - Mar 12th, 2026 5:08 am
Burning Rock Announces Results of 2025 Annual General Meeting - Dec 22nd, 2025 9:04 pm
Burning Rock Announces 2025 Annual General Meeting to be Held on December 23, 2025 - Dec 1st, 2025 2:11 am
This Undiscovered Biotech Stock Has Quintupled in a Year and Just Hit New Highs - Nov 26th, 2025 9:10 am
Burning Rock Reports Third Quarter 2025 Financial Results - Nov 19th, 2025 11:52 pm
Liquid Biopsy for Early Cancer Detection and Monitoring Market Report 2025-2033, with Profiles of GRAIL, AnchorDx, Burning Rock Biotech, Genecast, Guardant Health, Elypta, Freenome, and Oncimmune - Oct 6th, 2025 7:20 am
Burning Rock's OncoGuide™ OncoScreen™ Plus CDx System Now Approved in Japan as a Companion Diagnostic for Capivasertib in Breast Cancer - Sep 24th, 2025 12:42 am
Burning Rock Reports Second Quarter 2025 Financial Results - Sep 7th, 2025 11:39 pm